	Le Bénéfice D'Exploitation		Date
Abbott	USD 2.25B	73M	2025-12
AtriCure	USD 2.49M	2.28M	2025-12
Baxter International	USD -214.2M	415.4M	2025-12
Becton, Dickinson and Co.	USD 663M	163M	2025-12
Boston Scientific	USD 1.24B	203M	2025-12
Cooper Companies	USD 140.4M	35.3M	2025-09
Danaher	USD 1.5B	348M	2025-12
Dexcom	USD 323M	80.5M	2025-12
Edwards Lifesciences	USD 370.3M	54.8M	2025-12
Globus Medical	USD 181.31M	298.83M	2025-12
Hologic	USD 237M	16M	2025-12
Inogen	USD -7.79M	728K	2024-09
Insulet	USD 146.3M	28.6M	2025-12
Integra LifeSciences	USD 66M	54.24M	2025-12
Intuitive Surgical	USD 865.3M	97.5M	2025-12
J&J	USD 5.59B	1.81B	2025-12
Masimo	USD 83.6M	19.1M	2025-09
Medtronic	USD 1.74B	40M	2025-12
Merit Medical Systems	USD 54.2M	11.58M	2025-12
Philips	EUR 719M	390M	2025-12
Smith & Nephew	USD 440M	50M	2025-12
Stryker	USD 1.97B	609M	2025-12
Tandem Diabetes Care	USD 8.29M	31.16M	2025-12
Teleflex	USD 36.34M	445.24M	2025-12
Terumo	JPY 43.88B	1.21B	2025-12
Thermo Fisher Scientific	USD 2.3B	226M	2025-12
Zimmer Biomet Holdings	USD 302.9M	35.4M	2025-12

Medtronic Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.